Artivion | CRY - Frais De Vente Et D'Administration

Prix De L'Action
35.29
Variation Quotidienne
-1.10 -3.02%
Mensuellement
-8.46%
Annuel
45.53%
Q1 Prévisions
35.04




Frais De Vente Et D'Administration Changement Date
Abbott USD 3.13B 125M 2025-12
Accuray USD 127.32M 500.16M 2025-09
AngioDynamics USD 36.57M 3.79M 2025-09
Artivion USD 55.75M 4.54M 2025-12
AtriCure USD 78.34M 109K 2025-12
Baxter International USD 761M 53M 2025-12
Becton, Dickinson and Co. USD 1.39B 27M 2025-12
Boston Scientific USD 1.83B 93M 2025-12
Edwards Lifesciences USD 602.9M 88.3M 2025-12
Inogen USD 43.77M 510K 2024-06
Integra LifeSciences USD 156.45M 12.6M 2025-12
J&J USD 6.75B 831M 2025-12
Mesa Laboratories USD 27.31M 380K 2024-09
Orthofix International USD 130.35M 11.31M 2025-12
Pfizer USD 4.08B 894M 2025-12
ResMed USD 278.4M 19.2M 2025-12
Stryker USD 2.14B 150M 2025-12
Surmodics USD 14.58M 2.05M 2024-09
Tandem Diabetes Care USD 99.86M 5.34M 2025-12
Teleflex USD 222.37M 59.4M 2025-12
Terumo JPY 105.26B 7.38B 2025-12
Trinity Biotech USD 6.19M 2.18M 2025-09